Stock search

Ticker or company name

Compare stocks

Market: US

  • DOCHealthpeak Properties
  • REGRegency Centers
  • WYWeyerhaeuser

Add stock

Ticker or company

Summary

DOC
Healthpeak Properties
$19,84Down −0,70%
Year: Up +14%
56/100Ratio would watch
Open stock page
REG
Regency Centers
$76,58Up +0,62%
Year: Up +9%
57/100Best scoreRatio would watch
Open stock page
WY
Weyerhaeuser
$20,68Down −0,62%
Year: Down −7%
33/100Ratio would not consider buying
Open stock page

Verdict

REG has the best score (57). DOC grows revenue the fastest. REG is the cheapest by forward P/E. REG has the lowest debt load. REG has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckDOC3 ✓ 3 — 2 ✕REG3 ✓ 2 — 2 ✕WY1 ✓ 4 — 4 ✕
P/E vs its history37,426,532,3
P/E vs industry37,426,532,3
Forward P/E65,229,643,3
Revenue growth, YoY+9,4%+7,8%−1,1%
EPS growth, YoY—n/a—+40,0%
Net margin13,7%35,4%6,5%
Net debt / EBITDAn/a—3,13,8
Free cash flow$1,27 bn$819 m$530 m
Share count over a year−0,8%n/a—−0,1%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterDOCTTMREGTTMWYTTMIndustry medianTTM
P/E TTM ↓Worst: 37,4Best: 26,532,332,0
Forward P/E ↓Worst: 65,2Best: 29,643,333,1
PEG ↓n/aBest: 1,0Worst: 1,01,2
P/S TTM ↓4,6Worst: 8,5Best: 2,17,5
EV/EBITDA ↓Best: 13,1Worst: 19,014,719,3
P/FCF ↓Worst: 133,0Best: 49,357,141,0

Price, %

  • DOCn/a
  • REGn/a
  • WYn/a

Returns

Best WorstNo mark — in between

PeriodDOCREGWY
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

DOCREGWY
Share of “buy”Worst: 38%58%Best: 81%
Beat the forecastWorst: 3 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”Best: +200,0%Worst: −2,3%+69,8%
Insiders over 12 monthssales $340 810sales $39,9 msales $1,36 m

Details are on each stock page.